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Mesenteric artery disease in the elderly
Kimberley J. Hansen, MD,a David B. Wilson, MD,a Timothy E. Craven, MSPH,b Jeffrey D. Pearce,
MD,a William P. English, MD,a Matthew S. Edwards, MD,a Juan Ayerdi, MD,a and Gregory L. Burke,
MD, MS,b Winston-Salem, NC
Purpose: The purpose of this study was to estimate the population-based prevalence of mesenteric artery stenosis (MAS)
and occlusion among independent elderly Americans.
Method: As part of an ancillary investigation to the Cardiovascular Health Study (CHS), participants in the Forsyth
County, NC cohort had visceral duplex sonography of the celiac arteries and superior mesenteric arteries (SMAs). Critical
MAS was defined by celiac peak systolic velocity >2.0 m/s and/or SMA peak systolic velocity >2.7 m/s. Occlusion of
either vessel was defined by lack of a Doppler-shifted signal within the imaged artery. Demographic data, blood pressures,
and blood lipid levels were collected as part of the baseline CHS examination. Participants’ weights were measured at
baseline and before the duplex exam. Univariate tests of association were performed with two-way contingency tables,
Student t tests, and Fisher exact tests. Multivariate associations were examined with logistic regression analysis.
Results: A total of 553 CHS participants had visceral duplex sonography technically adequate to define the presence or
absence of MAS. The study group had a mean age of 77.2  4.9 years and comprised 63% women and 37% men.
Participant race was 76% white and 23% African-American. Ninety-seven participants (17.5%) had MAS. There was no
significant difference in age, race, gender, body mass index, blood pressure, cholesterol, or low-density lipoproteins for
participants with or without MAS. Forward stepwise variable selection found renal artery stenosis (P  .008; odds ratio
[OR], 2.85; 95% confidence interval [CI], 1.31, 6.21) and high-density lipoprotein >40 (P  .02; OR, 3.03; 95% CI,
1.17, 7.81) significantly associated with MAS in a multivariate logistic regression model. Eighty-three of the 97
participants with MAS (15.0% of the cohort) had isolated celiac stenosis. Seven participants (1.3% of the cohort) had
combined celiac and SMA stenosis. Five participants (0.9% of the cohort) had isolated SMA stenosis. Two participants
(0.4% of the cohort) had celiac occlusion. Considering all participants with MAS, there was no association with weight
change. However, SMA stenosis and celiac occlusion demonstrated an independent association with annualized weight
loss (P  .028; OR, 1.54; 95% CI, 1.05, 2.26) and with renal artery stenosis (P .001; OR, 9.48; 95% CI, 2.62, 34.47).
Conclusion: This investigation provides the first population-based estimate of the prevalence of MAS among independent
elderly Americans. MAS existed in 17.5% of the study cohort. The majority had isolated celiac disease. SMA stenosis and
celiac artery occlusion demonstrated a significant and independent association with weight loss and concurrent renal
artery disease. (J Vasc Surg 2004;40:45-52.)Modern concepts of mesenteric artery disease in the
elderly began when Councilman1 reported three cases of
superior mesenteric artery (SMA) occlusion associated with
abdominal pain over a century ago. Although he correctly
suggested that gradual occlusion of major mesenteric arter-
ies could be responsible for intestinal ischemia causing
abdominal pain, his reasoning seemed flawed. Autopsy evi-
dence demonstrated that severe mesenteric artery stenosis
(MAS) or occlusion could occur without abdominal pain.2 In
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doi:10.1016/j.jvs.2004.03.022fact, Osler3 maintained that abdominal pain in conjunction
with systemic atherosclerosis associated with MAS reflected
coronary artery disease and myocardial ischemia.
Despite these early controversies, a relationship be-
tween multiple-vessel MAS and intestinal symptoms is now
well recognized. However, the diagnosis and management
of MAS remains enigmatic.4 This is especially true in the
elderly, in whom shared symptomatology with other dis-
eases may contribute to the diagnostic dilemma. All too
often, MAS associated with chronic symptoms may
progress to inanition or to acute on chronic mesenteric
ischemia with resultant intestinal gangrene.5 These unac-
ceptable outcomes reflect delayed definitive therapy, in part
due to the diagnostic challenge posed by the disease. In this
regard, the proportion of MAS contributing to recogniz-
able symptoms in the elderly is poorly characterized.
Data regarding these important issues are lacking be-
cause the prevalence of MAS in the elderly population is not
known. In the past, estimates of MAS were made from case-
series autopsy6-11 and angiographic12-15 studies. Popula-
tion-based estimates were not available because evaluation
of the mesenteric arteries required angiography. Recently, a
number of less invasive methods of evaluation have been
developed and validated. Among these, visceral duplex45
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based study of MAS.16 This non-invasive study poses no
participant risk, and requires only an overnight fast for
preparation.
This report uses VDS to determine the prevalence of
MAS among independent, community-dwelling elderly
participants in the Forsyth County cohort of the Cardio-
vascular Health Study (CHS).17 Specific areas of interest
include (1) prevalence of celiac and SMA stenosis or occlu-
sion; (2) the association of MAS with demographic charac-
teristics, atherosclerotic risk factors, and antecedent weight
loss.
METHODS
The Cardiovascular Health Study. The design of the
Cardiovascular Health Study (CHS) has been previously
described.17 Briefly, the CHS is a prospective, multicenter,
observational cohort study of cardiovascular disease risk
factors, morbidity, and mortality among Americans over
the age of 65. The initial CHS cohort was recruited from a
randomly selected sample of Medicare eligible individuals
in four US communities (Forsyth County, NC; Sacramento
County, Calif; Washington County, Md; and Allegheny
County, Pa). Initial recruitment was performed between
April 1989 and May 1990. A supplemental cohort of
predominantly African-American participants was recruited
by the same methods from June 1992 to June 1993 to
allow for racial subgroup analyses.
All CHS enrollees underwent a baseline examination
consisting of a detailed medical history and clinical exami-
nation. Clinical examination included physical examination
and phlebotomy, which included measurement of serum
creatinine levels. Annual follow-up examinations were per-
formed to update medical history data, assess the occur-
rence of cardiovascular disease events, and repeat portions
of the clinical examination at previously defined intervals.17
Weights were measured on a single, calibrated eye-level
physician scale (Detecto, Webb City, Mo) with partici-
pants’ outer garments, shoes, and pocket contents re-
moved. Blood pressure and weight measures were taken at
each annual follow-up visit. Repeat phlebotomy was per-
formed in 1992 and 1993, 1996 and 1997, and at the time
of the visceral duplex examination.
Visceral duplex sonography. As an ancillary study
funded through the National Institute of Diabetes and
Digestive and Kidney Disease, CHS participants in the
Forsyth County cohort received abdominal duplex sonog-
raphy between January 1995 and February 1997. The
primary aim of this ancillary study was to define the preva-
lence of renovascular disease in the Forsyth County cohort.
An additional goal was to determine the presence or ab-
sence of mesenteric artery disease, defined as celiac axis and
SMA stenosis or occlusion. Participants scheduled for rou-
tine annual examination were contacted by telephone and
informed of this ancillary project. This study was approved
by the Wake Forest University Human Subjects Review
Committee.VDS was performed with an Ultramark-9 HDI Ultra-
sound System (Advanced Technologies Laboratories,
Bothell, Wash). All VDS was performed by two registered
vascular technologists with extensive experience in abdom-
inal duplex evaluation. Written informed consent was ob-
tained from CHS participants on return for their annual
examination. During that same visit, consenting partici-
pants were studied with VDS at the CHS Forsyth County
Field Center. As part of the annual examination, CHS
participants had fasted overnight.
A complete study examined both renal arteries, the
celiac axis, and SMA. Renal duplex sonography was per-
formed first followed by VDS. To minimize participant
burden, the protocol design allowed 20 minutes for com-
pletion of the entire examination. With the participant
supine, a 2.25-MHz or 3.0-MHz ultrasound probe was
coupled to the abdominal skin with acoustic gel 3 or 4 cm
inferior to the xiphoid process. Interrogation of each renal
artery and kidney was performed as described previously.18
The SMA was then scanned longitudinally for its first 5 cm.
PSV was recorded at an angle of insonation 60°. The
celiac artery was then imaged during shallow respiration to
its bifurcation. PSV along the vessel’s length was recorded
at an angle of insonation 60°.
All B-mode and Doppler spectral data were collected
on super VHS tape and transferred to an electronic data-
base. This process was repeated and the data compared for
agreement. A 3% discordance in electronic data was adju-
dicated from review of the original duplex study.
For the purposes of this report, VDS study was consid-
ered negative or positive for hemodynamically significant
MAS or inadequate for interpretation according to the
following criteria: (1) VDS was negative for MAS when
celiac artery PSV from aortic origin to bifurcation was2.0
m/s and SMA PSV was2.7 m/s for its first 5 cm; (2) VDS
was positive for MAS (70% diameter-reducing stenosis)
when there was a focal increase in celiac artery PSV 2.0
m/s, or a focal SMA increase in PSV 2.7 m/s, or no
Doppler signal obtained from an imaged artery (arterial
occlusion); (3) VDS was technically inadequate for inter-
pretation when the mesenteric vessel was not imaged or
when celiac or SMA Doppler signals were not obtained
from aortic origin to its first major branch. These VDS
criteria for 70% diameter-reducing arterial stenosis have
been validated prospectively in comparison with conven-
tional mesenteric angiography.16 Accuracy of mesenteric
sonography in the Wake Forest University clinical vascular
lab was retrospectively reviewed. Over a 3-year period, 372
mesenteric duplex exams were performed. Of these, 47
patients had both mesenteric duplex and angiography avail-
able for review. Overall SMA accuracy was 94%, and celiac
accuracy was 83%. Sensitivity in the SMA and celiac were
100% and 82%, respectively. Specificity in the SMA and
celiac were 95% and 86%, respectively.
Statistical analysis. After ancillary study data were
keyed and verified, results of duplex sonography exams
were matched with participant data provided by the CHS
coordinating center. Statistical comparison of CHS partic-
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evaluated by examining differences in baseline characteris-
tics (2 tests for categorical factors, t tests for continuous
factors) between the two groups. In addition, change in
weight was defined as the participant’s baseline weight
minus the weight at the time of VDS study in pounds.
Annualized weight loss is the change in weight divided by
the number of years between measurements. These are
continuous variables in the univariate analysis and dichot-
omous variables at 1 standard deviation change in the
multivariate model. For each, a positive number signifies
weight loss over time. Estimates of MAS prevalence were
computed for the group as a whole, and by gender and age
strata.
Description of baseline characteristics by MAS status
was examined by using means and standard deviations (for
continuous factors) or relative frequencies (for categorical
factors). Prevalence odds ratios (OR) of MAS were esti-
mated for each factor via univariate logistic regression
models. A “best” multivariate logistic regression model to
predict MAS was constructed by using a forward stepwise
variable selection procedure where, beginning with the
most significant, candidate variables with a P value 0.10
were selected one by one for model inclusion. All variables
remaining significant at a 0.05  level were included in the
final model.19
Analysis was performed for the group with any hemo-
dynamically significant stenosis of the celiac or SMA as
defined previously. In addition, the same analysis was re-
peated for the subgroup with SMA disease, either alone or
in combination with the celiac, or with complete occlusion
of the celiac axis (SMA/CeO).
This subgroup analysis was performed to minimize the
presence of extrinsic celiac compression. The SMA/CeO
Table I. Demographics and baseline atherosclerotic risk fa
Variable Definition
Age* (y) Mean, SD
Gender
Male (%)
Female (%)
Systolic blood pressure mm Hg (mean, SD)
Diastolic blood pressure mm Hg (mean, SD)
Clinical hypertension Systolic blood pressure 160 mm
diastolic blood pressure 95 m
taking antihypertensive medica
Diabetes mellitus Fasting glucose 140 mg/dL or
glucose load 200 mg/dL or
or oral hypoglycemic agent (%)
Renal insufficiency serum Cr 1.5 mg/dL (male), 
Cigarette smoking Current or former smoker (%)
Hypercholesterolemia Total cholesterol 240 mg/dL (
Elevated LDL-C LDL-C 130 mg/dL (%)
Decreased HDL-C HDL-C 40 mg/dL (%)
Obesity Greater than 130% ideal body we
CHS, Cardiovascular Health Study; LDL-C, low-density lipoprotein; HDL-
*Age at the time of visceral duplex sonography.subgroup was considered to represent a conservative esti-
mate of MAS or occlusion due to atherosclerosis.
RESULTS
Between January 1995 and February 1997, 1245 For-
syth County participants returned to the CHS Field Center
for annual examination. Among returning participants, 870
gave consent for duplex sonography, providing 69.9% re-
cruitment efficiency. Table I defines the atherosclerotic risk
factors examined and compares the CHS participants who
accepted and declined VDS. Compared with participants
studied with VDS, participants not evaluated were signifi-
cantly older, had higher systolic blood pressures, were more
likely to have renal insufficiency, and had a greater rate of
tobacco use. They had a lower prevalence of obesity.
A total of 870 participants consented to VDS examina-
tion. This group consisted of 544 women (63%) and 326
men (37%), with a mean age of 77.3  4.9 years. Partici-
pant race was 76% Caucasian and 23% African-American.
The average time for abdominal duplex examination was
18.3  3.9 minutes.
Of these 870 abdominal duplex examinations, 553
(62%) were technically satisfactory to define the presence or
absence of MAS. Table II compares demographic charac-
teristics and atherosclerotic risk factors between the 553
participants with technically satisfactory VDS and the 317
participants who had technically inadequate studies. Com-
pared with technically satisfactory examinations, partici-
pants with inadequate VDS were more likely male, had
higher rates of tobacco abuse, and demonstrated signifi-
cantly higher body mass indexes at baseline.
Overall, 97 of 553 participants (17.5%) with technically
adequate VDS demonstrated MAS (Table III). Of the 97
participants with MAS, 83 (86%) had isolated celiac steno-
among CHS participants (N  1245)
Recruited
(n  870)
Non-recruited
(n  375) P
77.3  4.9 79.7  5.9 .001
.753
37.5 36.5 –
62.5 63.5 –
135  21 139  23 .001
72  10 73  12 .209
or 41.4 46.1 .126
g or
%)
ost
insulin
20.8 24.8 .121
female) 7.1 14.0 .001
46.4 56.1 .002
18.3 18.8 .859
16.6 18.1 .502
16.2 15.2 .655
%) 30.2 24 .025
h-density lipoprotein.ctors
Hg
m H
tion (
2-h p
taking
1.3 (
%)
ight (
C, hig
line.
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had isolated SMA stenosis, and 2 (2%) had celiac occlusion.
The prevalence of each of these anatomic subgroups of
MAS within the entire study cohort was 15.0%, 1.3%, 0.9%,
and 0.4%, respectively.
Table IV summarizes the prevalence of MAS relative to
age strata at the time of duplex examination. The distribu-
tion of MAS by age strata was 65 to 69 years (4/19;
Table II. Summary statistics for CHS participants studied
Variable
Technically sa
(n  55
Age (mean, SD)* 77.3 
Gender
Male (%) 31.1
Female (%) 68.9
Systolic blood pressure (mean, SD) 135 
Diastolic blood pressure (mean, SD) 72 
Clinical hypertension (%) 40.8
Diabetes mellitus (%) 18.4
Renal insufficiency (mean, SD) 7.2
Smoking (%) 43.5
Hypercholesterolemia (%) 19.9
Elevated LDL-C (%) 17.6
Decreased HDL-C (%) 14.4
Body mass index (mean, SD) 26 
Obesity (%) 28.4
CHS, Cardiovascular Health Study; LDL-C, low-density lipoprotein; HDL-
*Age at time of renal duplex sonography all other variables assessed at base
Table III. Prevalence of MAS by anatomic location
Category (participants)
Prevalence
within cohort
All mesenteric stenosis (n  97) 17.5%
Isolated celiac stenosis (n  83) 15.0%
Combined celiac and SMA stenosis (n  7) 1.3%
Isolated SMA stenosis (n  5) 0.9%
Celiac occlusion (n  2) 0.4%
MAS, Mesenteric artery stenosis; SMA, superior mesenteric artery.
Table IV. Prevalence of MAS among participants with
technically satisfactory VDS
Category (participants)
Prevalence
of MAS†
Prevalence of
SMA/CeO‡
Overall (n  553) 17.5% 2.5%
Age strata*
65 to 69 years (n  19) 21.1% 5.3%
70 to 74 years (n  197) 14.2% 2.0%
75 to 79 years (n  213) 19.7% 2.4%
80 years (n  124) 18.6% 3.2%
Gender
Female (n  381) 18.9% 3.2%
Male (n  172) 14.5% 1.2%
VDS, Visceral duplex sonography; MAS, mesenteric artery stenosis.
*Age at time of VDS.
†SMA stenosis, SMA and celiac stenosis, celiac occlusion, or celiac stenosis.
‡SMA stenosis, SMA and celiac stenosis, or celiac occlusion.21.1%), 70 to 74 years (28/197; 14.2%), 75 to 79 years
(42/213; 19.7%), and 80 years (23/124; 18.6%). In
addition, the prevalence of MAS in the SMA/CeO sub-
group is described. For those participants with either SMA
stenosis or celiac occlusion, the distribution of disease by
age strata was 65 to 69 years (1/19; 5.3%), 70 to 74 years
(4/197; 2.0%), 75 to 79 years (5/213; 2.4%), and 80
years (4/124; 3.2%).
Table V summarizes the univariate analysis of demo-
graphic features and atherosclerotic risk factors and the
presence of MAS. HDL-C40 mg/dL and the presence of
renal artery stenosis demonstrated univariate associations
with MAS. None of the atherosclerotic risk factors defined
in Table I had a statistically significant association with
MAS. Hypertension, tobacco use, diabetes mellitus, obe-
sity, hypercholesterolemia, and elevated low-density li-
poprotein–C had no apparent association with MAS when
considered as either categorical or continuous variables by
univariate analyses. Multivariate analysis confirmed signifi-
cant associations between high-density lipoprotein 40
mg/dL (P  .022; OR, 0.33; 95% confidence interval
[CI], 0.13, 0.85) and the presence of renal artery stenosis
(P .008; OR, 2.85; 95% CI, 1.31, 6.19) with MAS.
Overall, 32 of 539 participants (6%) lost10% of their
baseline body weight over the study interval. Of the partic-
ipants with weight data, 423 had no evidence of mesenteric
stenosis and a mean weight gain of 0.1 pound. The 86
participants with MAS who had weight data lost an average
of 1.7 pounds. The 12 participants in the SMA/CeO
subgroup with baseline and follow-up weight measure-
ments lost an average of 7.0 pounds.
Table VI summarizes a univariate analysis of partici-
pants with SMA stenosis, isolated or in combination with
celiac stenosis, or celiac occlusion (SMA/CeO) compared
with participants with either no MAS or with isolated celiac
stenosis only. In this analysis, weight loss (P .018; OR, 1.92;
95% CI, 1.12, 3.30) and the presence of renal artery steno-
sceral duplex sonography (N  870)
tory Technically incomplete
(n  317) P
77.5  5.0 .576
48.6
51.4 .001
135  20 .762
73  10 .305
42.6 .600
23.9 .078
6.8 .801
51.3 .028
15.6 .111
14.8 .294
19.4 .058
27  4.6 .001
33.4 .119
h-density lipoprotein.by vi
tisfac
3)
4.9
21
11
4.4
C, hig
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cant associations with SMA stenosis or celiac occlusion.
A multivariate analysis after forward step-wise variable
selection was performed for the SMA/CeO subgroup. An
annualized standard deviation decrease in body weight (P
.028; OR, 1.54; 95% CI, 1.05, 2.26) and the presence of
renal artery stenosis ((P .001; OR, 9.48; 95% CI, 2.62,
34.37) had significant and independent associations with
SMA stenosis or celiac occlusion.
Table V. Results of univariate analysis for MAS and associ
Variable
Participants with
MAS (n  86)
P
Age† 78.0  5.2
Gender (male)
Male (%) 23 (26.7)
Female (%) 63 (73.3)
Renal artery stenosis (%)‡ 11 (12.8)
Clinical hypertension (%) 42 (48.8)
Diabetes 17 (19.8)
Smoking 38 (44.2)
Hypercholesterolemia (%) 20 (23.3)
Elevated LDL-C (%) 21 (24.4)
Decreased HDL-C (%) 5 (5.8)
Systolic blood pressure§ 137.6  22.8
Diastolic blood pressure§ 71.9  10.0
Body mass index§ 25.6  4.1
Weight loss§ 1.7  11.2
Annualized weight loss§ 0.3  2.7
MAS, Mesenteric artery stenosis; CI, confidence interval; LDL-C, low-dens
*Analysis for participants with data for all factors only.
†Odds ratio per 5-y increase.
‡Renal artery peak systolic velocity 1.8 m/s.
§Odds ratio per standard deviation change.
Table VI. Results of univariate analysis for SMA stenosis/
Variable*
SMA/CeO present
(n  12)
Age† 77.6  4.7
Gender (male)
Male (%) 2 (16.7)
Female (%) 10 (83.3)
Renal artery stenosis (%)‡ 4 (33.3)
Clinical hypertension (%) 4 (33.3)
Diabetes 3 (25.0)
Smoking 6 (50.0)
Hypercholesterolemia (%) 4 (33.3)
Elevated LDL-C (%) 4 (33.3)
Decreased HDL-C (%) 1 (8.3)
Systolic blood pressure§ 130.6  21.1
Diastolic blood pressure§ 71.3  10.4
Body mass index§ 26.6  5.1
Weight loss (lbs)§ 7.0  6.8
Annualized weight loss§ 1.5  1.3
SMA, Superior mesenteric artery; CeO, celiac occlusion; CI, confidence inte
*Analysis for participants with data for all factors only.
†Odds ratio per 5-y increase.
‡Renal artery peak systolic velocity 1.8 m/s.
§Odds ratio per standard deviation change.DISCUSSION
This study represents the first population-based esti-
mate of MAS in the elderly. Overall, 17.5% of this cohort
demonstrated celiac and/or SMA stenosis or occlusion.
The majority of MAS was defined by isolated celiac artery
stenosis, and MAS had a significant association with con-
comitant renovascular disease. Considering only CHS par-
ticipants with SMA stenosis, isolated or in combination
with celiac stenosis, or celiac occlusion, MAS demonstrated
risk factors*
pants without
(n  423)
Odds
ratio 95% CI P
.1  4.7 1.23 0.98, 1.53 .075
0.78 0.46, 1.31 .346
5 (31.9)
8 (68.1)
2 (5.2) 2.67 1.24, 5.74 .012
9 (37.6) 1.59 0.99, 2.53 .053
0 (18.9) 1.06 0.59, 1.89 .854
5 (43.7) 1.02 0.64, 1.63 .939
5 (20.1) 1.21 0.69, 2.10 .509
2 (17.0) 1.58 0.91, 2.74 .108
4 (15.1) 0.35 0.14, 0.89 .027
.1  20.3 1.24 0.98, 1.57 .072
.8  10.8 1.01 0.80, 1.78 .941
.1  4.4 0.87 0.68, 1.12 .281
.1  9.7 1.13 0.91, 1.39 .237
.0  2.6 1.14 0.91, 1.41 .245
protein; HDL-C, high-density lipoprotein.
occlusion group and associated risk factors*
/CeO absent
n  497)
Odds
ratio 95% CI P
.2  4.8 1.09 0.62, 1.91 .760
0.44 0.10, 2.02 .289
56 (31.4)
41 (68.6)
29 (5.8) 8.09 2.30, 28.43 .005
97 (39.6) 0.76 0.23, 2.56 .660
94 (18.9) 1.43 0.38, 5.38 .598
17 (43.7) 1.29 0.41, 4.06 .663
01 (20.3) 1.96 0.58, 6.64 .280
89 (17.9) 2.29 0.62, 1.77 .183
68 (13.7) 0.57 0.28, 4.51 .597
.9  20.8 0.84 0.46, 1.55 .579
.9  10.6 0.94 0.53, 1.69 .841
.9  4.3 1.16 0.66, 2.02 .615
.1  10.0 1.92 1.12, 3.30 .018
.1  2.7 1.44 0.99, 2.11 .057
DL-C, low-density lipoprotein; HDL-C, high-density lipoprotein.ated
artici
MAS
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13
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2
15
8
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7
6
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Early autopsy and angiographic case series demon-
strated some degree of MAS in 12% to 60% of subjects;
however intestinal ischemia associated with MAS was ex-
ceedingly rare.6-8,12,13 Although these reports drew atten-
tion to MAS, the early case series shared a number of
common limitations. Numbers of mesenteric arteries exam-
ined in each series were small and subjects were generally
selected on the basis of the presence of advanced athero-
sclerosis. Methods to estimate the presence and severity of
disease were variable and MAS was not related to intestinal
ischemia. In contrast to these limitations, the present study
provides an estimate of 70% celiac and SMA stenosis or
occlusion in a population-based cohort and relates this
anatomic disease to one of the hallmark signs of chronic
intestinal ischemia—decrease in body weight over time.
In the current report, the prevalence of MAS is lower
than that observed in many earlier case series, but closely
approximates the more recent report of Valentine and co-
workers.20 These investigators reported a case series of
consecutive angiographic studies in men evaluated for aor-
tic aneurysm and occlusive disease or lower extremity isch-
emia. A75% diameter-reducing stenosis or occlusion was
noted in 11.7% of celiac and 2.9% of SMAs. Overall, 2.9% of
patients had significant stenoses of both celiac and SMAs.
No patient demonstrated symptoms of intestinal ischemia,
but a significant association was observed between unsus-
pected renovascular disease and MAS—an observation also
demonstrated in this CHS cohort.
Few data are available that correlate MAS with the risk
of intestinal ischemia. Dunphy’s21 classic observations relating
intestinal symptoms with death from intestinal gangrene have
not been replicated in a prospective series. In an attempt to
define the clinical course of MAS, Thomas and colleagues22
reviewed 980 consecutive angiograms to identify 82 patients
with50% stenosis of at least one mesenteric artery. Seventy-
two patients were interviewed for symptoms of intestinal
ischemia every 6 months. Overall, four patients developed
symptoms of chronic intestinal ischemia before follow-up of
2.6 years. In each instance, patients with follow-up intestinal
symptoms had significant stenosis of all 3 mesenteric arteries
(ie, celiac, superior, and inferior). This study demonstrates the
diagnostic dilemma associated with MAS. Multiple mesenteric
artery disease, which is generally considered necessary for
symptomatic intestinal ischemia, was observed in only 1.5% of
patients. Even when multiple mesenteric arteries were diseased,
only one in four patients developed intestinal symptoms.
The current study demonstrated a number of features
similar to the Thomas et al findings. Even though 17.5% of
this population had MAS, SMA stenosis or celiac occlusion
was present in only 2.5%. Despite the fact that the intestinal
risk of MAS would be presumed low, the finding of a
significant and independent association between this pat-
tern of MAS and annualized weight loss in a population-
based study is a concern. Data gathered as part of the CHS
do not allow assessment of intestinal symptoms in thecohort; however, follow-up of this subgroup may provide
important estimates of intestinal risk associated with MAS.
A number of unique data are provided by this study,
but a number of study limitations deserve comment. In-
dexed subjects from the CHS were collected through a
two-step random process; however, eligible members from
the sampled individual’s household were also recruited.23
This strategy was intended to enhance recruitment and
retention of the elderly cohort for longitudinal observation.
As a result, the final CHS cohort consisted of 70% of those
initially sampled and 30% who were recruited because they
shared the same household. This recruitment strategy may
have introduced an important source of bias, since signifi-
cant differences existed between randomly selected partic-
ipants and those who chose not to participate in the CHS.
The refusal rate was higher among women than men and
enrolled participants were younger, more highly educated,
more likely to be married, and less likely to be smokers.23 In
addition to this “healthy cohort” effect, the recruitment for
VDS may have introduced other sources of bias. Compared
with the 870 CHS participants recruited for duplex study,
the 375 participants who declined study were older, had a
greater history of tobacco use, and had a significantly lower
instance of obesity. Each of these characteristics may have
contributed to an underestimation of MAS.
In addition, requirements of the duplex protocol may
have introduced unintended bias. VDS was performed in
this cohort as part of an ancillary study that included renal
duplex sonography. The specific aim of the duplex examina-
tion was to determine the presence or absence of hemody-
namically significant renal artery stenosis or occlusion. The
evaluation for MAS or occlusion was a secondary aim. To
minimize the study burden on this elderly cohort, the duplex
protocol limited the entire examination to 20 minutes. Nine-
ty-six percent of renal duplex examinations were technically
satisfactory; however, study time was inadequate for simulta-
neous VDS in one third of participants.18 Compared with
participants with adequate VDS, participants with inadequate
studies were more likely men with a history of tobacco use.
Despite these study limitations, the Forsyth County
CHS cohort provided a large, diverse group of community-
dwelling men and women for VDS.17,23 The results from
VDS in combination with data already collected or being
collected as part of CHS will provide important informa-
tion regarding mesenteric artery disease. Continued fol-
low-up of this cohort may provide important estimates of
intestinal risk associated with MAS.
In summary, MAS was present in 17.5% of indepen-
dent, community-dwelling elderly men and women. MAS
demonstrated no association with age, race, gender, or
hypertension. The presence of SMA stenosis or celiac artery
occlusion had significant and independent associations with
both annualized weight loss and concomitant renovascular
disease. Continued follow-up of this cohort may provide
unique estimates regarding the intestinal risk of MAS and
provide rationale for management of mesenteric artery
disease in the elderly.
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Available online May 5, 2004.DISCUSSIONDr Raymond S. Martin (Nashville, Tenn). This interesting
report prompted me to review the incidental finding of unsus-
pected MAS in our office laboratory. Though we have not screened
the general elderly population, I selected 100 consecutive abdom-
inal arterial duplex scans done for aortic aneurysm surveillance in
patients over 65 years of age.
As in other studies of patients with established advanced
atherosclerosis, the overall prevalence of MAS was much higher, at
47%, than in Dr Hansen’s study. Using the same systolic velocity
criteria, 22 patients had renal artery stenosis, 42 had celiac stenosis,
20 had SMA stenosis, and 13 had stenosis of both major mesen-
teric vessels. Though these two cohorts are certainly not compara-
ble, both demonstrate that celiac stenosis is far more common than
SMA stenosis in asymptomatic patients.
My review of the paper raised the following 3 questions for
discussion.
First, your study and others confirm a prevalence of mesenteric
vascular disease far higher than the incidence of clinically symp-
tomatic mesenteric ischemia. Does the use of the single simplistic
criterion of peak systolic velocity overestimate this disease as com-
pared with the estimates given by arteriography? Would the use of
diastolic velocities, wave form analysis, or other criteria commonly
employed in carotid evaluation give a more accurate picture?
Second, impingement of the median arcuate ligament on the
celiac trunk is commonly seen on lateral aortograms. Do you know
whether some patients you identified with celiac stenosis might
have this phenomenon, resulting in overestimation of the preva-
lence of this lesion? It certainly does affect the overall estimate if
you really don’t know how many of these had atherosclerotic
plaque versus median arcuate ligament syndrome.
Finally, you noted a significant fall in body weight in individ-
uals with SMA stenosis or celiac occlusion as compared with those
with celiac stenosis alone or no mesenteric artery stenosis. Werethese patients otherwise symptomatic, and did any of them have
infarction or clinical incidence during the course of follow-up? Your
discovery of these patients with mesenteric artery stenosis and weight
loss raises the question, is intervention indicated in patients with
mesenteric artery stenosis and weight loss but no abdominal pain?
Dr David B. Wilson. We base the revascularization of the
mesenterics on symptoms of postprandial pain and food fear and
not just on weight loss. The finding of weight loss in a population
we found interesting. What makes this study unique is that it
wasn’t performed on patients. While duplex exam isn’t being
advocated to screen for mesenteric stenosis in the general popula-
tion, it is useful for patients selected through clinical criteria to have
a high likelihood of disease.
You asked about the follow-up of our subgroup with SMA
disease or celiac occlusion. We have taken a preliminary look at the
outcomes and overall events in that group, and with a first look at
the data through 2001 we did not see an association between the
presence of disease and all-cause mortality or cardiac events. Un-
fortunately, the CHS is very well characterized in certain areas,
such as whether a patient likes to eat his chicken with the skin on or
the skin off, but it doesn’t address whether or not he has pain after
eating, so we don’t have a lot of information about gastrointestinal
symptoms.
The relevance of the median arcuate ligament compression
isn’t addressed in our data. Unfortunately duplex sonography is
unable to distinguish between intrinsic arterial disease and extrinsic
compression. We performed the subgroup analysis to exclude
those patients most likely to have extrinsic compression, and this
does make a conservative estimate of the impact of atherosclerosis
in the population overall.
The first question was does peak systolic velocity alone over-
estimate the presence of stenoses and would diastolic velocities or
other measurements add to the accuracy? In our pilot study we did
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about 20% disease prevalence, we found that the peak systolic
velocity alone at 2.7 m/s for the SMA or 2.0 m/s for the celiac had
the highest accuracy—positive and negative predictive values to
correlate with a 70% angiographic stenosis.
Dr Mitchell Goldman (Knoxville, Tenn). Does inspiration
and expiration affect the velocity in your median arcuate syndrome
patients, number one? And how about feeding them and checking
them again, especially in the combined patients where you have
celiac and SMA disease, to see if you actually have an outcome
effect or a functional effect. Since you are only dealing with 80-odd
patients, it might be worthwhile to go back and grab that cohort
and chase them a little bit.Dr Wilson. Inspiration/expiration duplex views can help
differentiate between diaphragmatic compression and intrinsic dis-
ease with accelerated velocities in end expiration consistent with
compression. For our protocol the participants were breathing at a
slow normal comfortable rate and so we don’t have that informa-
tion. It is useful in a clinical setting.
The food trial has been described in a clinical setting, but these
patients were all fasting and so that might be a very useful adjunct
for patients with a clinical suspicion.
The patients in follow-up are now quite elderly, and it’s
difficult to get them into the clinic. But in those few who are still
coming back for visits, a food trial would be interesting. Thank
you.
